Once Upon a Farm, PBC is a Berkeley, California-based maker of organic baby and kids' food, best known for its cold-pressed pouches, frozen meals, soft-baked bars, melts, and puffs. Founded in 2015 and co-founded by actor Jennifer Garner and CEO John Foraker, the company completed its initial public offering on the New York Stock Exchange on February 6, 2026, pricing shares at $18 and raising roughly $200 million.
The company positions itself around USDA-certified organic, non-GMO products with no added sugar and no artificial ingredients, sold through more than 25,000 retail doors across mass, grocery, and natural channels as well as direct-to-consumer e-commerce. Its premium brand and fast revenue growth set it apart from larger legacy packaged-food players, which is why investors follow the OFRM stock closely despite its early-stage profitability profile. I also checked this using Tickeron’s AI Trend Prediction Engine to see how the stock compares to others in the industry.
Over the last 30 days, OFRM has dropped approximately 32%, from a closing price near $16.22 (the nearest prior trading session to 30 calendar days earlier) to about $11.04 in recent intraday trading. The bulk of that move came in a single session, when shares tumbled sharply following the product recall announcement and subsequent business update call.
The quarterly picture is similarly negative. Measured from an early-August closing level near $16.31, the stock has also declined roughly 32%. That extends a slide that began in July, when shares fell from above $21 to the mid-teens, and reflects a persistent downtrend rather than an isolated, single-event correction.
The dominant catalyst was the October 30 announcement that the company was voluntarily recalling its entire Tractor Wheels line of soft-baked bars after the FDA flagged three consumer reports of potential choking incidents involving toddlers. Because the company could not immediately pinpoint a root cause or isolate specific lots and flavors, it chose to recall all Tractor Wheels flavors and SKUs, and outlined a reformulation plan.
The news removed a meaningful product line from shelves and raised questions about near-term revenue and brand trust, prompting a sharp sell-off. Compounding the pressure, several analysts lowered their price targets in the weeks before the recall, including TD Cowen's cut to $18 from $20 in mid-October, against a backdrop of softness across the food and staples sector. The stock's high valuation relative to peers left it vulnerable to any negative fundamental news. From what I see, this kind of event often highlights how quickly sentiment can shift in high-growth names.
The quarterly decline is part of a broader post-IPO narrative. After its February debut, the stock initially traded above its $18 offer price, but its first earnings report as a public company reset expectations, with 2026 net sales guidance implying growth in the mid-to-high 20% range, a marked slowdown from 2025's roughly 53% revenue increase. That guidance deceleration, combined with repeated analyst price-target reductions through the year, weighed on sentiment.
Through July, shares fell from above $21 to the mid-teens as investors reassessed valuations for fast-growing, still-unprofitable consumer names. The August earnings report beat consensus estimates, but the relief was temporary. The October recall then accelerated the decline, reinforcing the market's focus on execution risk and brand safety in a premium-priced category. I’m watching this closely as the earnings release approaches.
The most immediate catalyst is the company's third-quarter earnings report on November 12, which should offer the first detailed financial read-through of the recall's scope and cost. Investors will also watch for updates on the recall's duration, any potential liabilities, the timeline for the Tractor Wheels reformulation, and whether the incident affects distribution or retailer shelf space across the rest of the portfolio.
Beyond the recall, key factors include the pace of distribution expansion, performance of newer product lines, and progress toward sustained profitability. Macroeconomic conditions, including consumer spending on premium organic products, and any further analyst rating or price-target changes will also shape the stock's path. The company's roughly $106 million cash position and debt-free balance sheet provide near-term financial flexibility, but execution on the recall recovery remains the central variable. One thing that stands out is how the balance sheet strength could help navigate the near-term challenges.
In my analysis of names like OFRM, I often turn to Tickeron’s AI Trading Bots to see how automated strategies are positioning around volatile consumer stocks. These tools help surface data-driven approaches that complement traditional research, especially when tracking recall impacts and valuation shifts. They provide a useful lens for comparing performance across different risk profiles without replacing core fundamental work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
OFRM's Aroon Indicator triggered a bullish signal on October 29, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 10 similar instances where the Aroon Indicator showed a similar pattern. In 8 of the 10 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 80%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where OFRM advanced for three days, in 32 of 41 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
OFRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OFRM as a result. In 7 of 9 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for OFRM turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 4 similar instances when the indicator turned negative. In 3 of the 4 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
OFRM moved below its 50-day moving average on October 21, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for OFRM crossed bearishly below the 50-day moving average on October 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 1 of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OFRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.062) is normal, around the industry mean (7.678). OFRM's P/E Ratio (-66.330) is considerably lower than the industry average of (6.461). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (2.382) is also within normal values, averaging (5.003).
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 68 (best 1 - 100 worst), indicating slightly worse than average price growth. OFRM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OFRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry FoodMajorDiversified